553 related articles for article (PubMed ID: 16098440)
1. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
2. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass.
Chung JH; Gikakis N; Rao AK; Drake TA; Colman RW; Edmunds LH
Circulation; 1996 Jun; 93(11):2014-8. PubMed ID: 8640976
[TBL] [Abstract][Full Text] [Related]
3. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII.
Khan MM; Hattori T; Niewiarowski S; Edmunds LH; Colman RW
Thromb Haemost; 2006 Mar; 95(3):462-8. PubMed ID: 16525574
[TBL] [Abstract][Full Text] [Related]
4. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
Philippou H; Adami A; Davidson SJ; Pepper JR; Burman JF; Lane DA
Thromb Haemost; 2000 Jul; 84(1):124-8. PubMed ID: 10928482
[TBL] [Abstract][Full Text] [Related]
6. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study.
Karkouti K; McCluskey SA; Syed S; Pazaratz C; Poonawala H; Crowther MA
Anesth Analg; 2010 Jun; 110(6):1533-40. PubMed ID: 20435945
[TBL] [Abstract][Full Text] [Related]
7. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
[TBL] [Abstract][Full Text] [Related]
8. A possible mechanism of action of activated factor VII independent of tissue factor.
Monroe DM; Hoffman M; Oliver JA; Roberts HR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S15-20. PubMed ID: 9819024
[TBL] [Abstract][Full Text] [Related]
9. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
11. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
12. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.
Asero R; Tedeschi A; Coppola R; Griffini S; Paparella P; Riboldi P; Marzano AV; Fanoni D; Cugno M
J Allergy Clin Immunol; 2007 Mar; 119(3):705-10. PubMed ID: 17204316
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentration of tissue factor and factor VII in patients after abdominal surgery.
Albrecht S; Müller S; Siegert G; Luther T; Müller M
Thromb Res; 1995 Mar; 77(6):557-62. PubMed ID: 7624841
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
15. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
16. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Torbet J
Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery.
Carson SD; Haire WD; Broze GJ; Novotny WF; Pirrucello SJ; Duggan MJ
Thromb Haemost; 1991 Nov; 66(5):534-9. PubMed ID: 1803617
[TBL] [Abstract][Full Text] [Related]
18. Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools?
Vieira LM; Dusse LM; Fernandes AP; Martins-Filho OA; de Bastos M; Ferreira MF; Cooper AJ; Lwaleed BA; Carvalho MG
Thromb Res; 2007; 119(2):157-65. PubMed ID: 16527335
[TBL] [Abstract][Full Text] [Related]
19. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
Nielsen VG
Ann Thorac Surg; 2006 May; 81(5):1720-7. PubMed ID: 16631662
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
Peverill RE; Teede HJ; Smolich JJ; Malan E; Kotsopoulos D; Tipping PG; McGrath BP
Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]